Multipotent (adult) and pluripotent stem cells for heart regeneration: What are the pros and cons?

Stem Cell Research and Therapy

Volumn 4, Issue 6, 2013, Pages

  Liao, Song Yan ^a   Tse, Hung Fat ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOTRANSPLANTATION; APOPTOSIS; AUTOTRANSPLANTATION; BONE MARROW CELL; CARDIAC STEM CELL; CELL DIFFERENTIATION; CELL FUNCTION; CELL RENEWAL; CONGESTIVE CARDIOMYOPATHY; EMBRYONIC STEM CELL; ENDOTHELIAL PROGENITOR CELL; ENGRAFTMENT; HEART FUNCTION; HEART INFARCTION; HEART PROARRHYTHMIA; HEART REGENERATION; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOCOMPETENT CELL; ISCHEMIC CARDIOMYOPATHY; MESENCHYMAL STEM CELL; MESENCHYMAL STROMA CELL; MULTIPOTENT STEM CELL; MYOBLAST; NONHUMAN; OUTCOME ASSESSMENT; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; SAFETY; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; TISSUE REGENERATION;

CELL- AND TISSUE-BASED THERAPY; HEART; HEART FAILURE; HUMANS; MYOCARDIAL INFARCTION; PLURIPOTENT STEM CELLS; REGENERATION;

EID: 84891476149     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt381     Document Type: Review

References (86)

1. Acute myocardial infarction. HD White, DP Chew, Lancet 2008 372 570 584 10.1016/S0140-6736(08)61237-4 18707987
2. Cardiac stem cell therapy and the promise of heart regeneration. JC Garbern, RT Lee, Cell Stem Cell 2013 12 689 698 10.1016/j.stem.2013.05.008 23746978
3. Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair. FS Loffredo, ML Steinhauser, J Gannon, RT Lee, Cell Stem Cell 2011 8 389 398 10.1016/j.stem.2011.02.002 21474103
4. Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells. TS Li, K Cheng, K Malliaras, RR Smith, Y Zhang, B Sun, N Matsushita, A Blusztajn, J Terrovitis, H Kusuoka, L Marban, E Marban, J Am Coll Cardiol 2012 59 942 953 10.1016/j.jacc.2011.11.029 22381431
5. Proarrhythmic risk of embryonic stem cell-derived cardiomyocyte transplantation in infarcted myocardium. SY Liao, Y Liu, CW Siu, Y Zhang, WH Lai, KW Au, YK Lee, YC Chan, PM Yip, EX Wu, Y Wu, CP Lau, RA Li, HF Tse, Heart Rhythm 2010 7 1852 1859 10.1016/j.hrthm.2010.09.006 20833268
6. Embryonic stem cells for severe heart failure: why and how? P Menasche, J Cardiovasc Transl Res 2012 5 555 565 10.1007/s12265-012-9356-9 22411322
7. Paracrine effects of direct intramyocardial implantation of bone marrow derived cells to enhance neovascularization in chronic ischaemic myocardium. HF Tse, CW Siu, SG Zhu, L Songyan, QY Zhang, WH Lai, YL Kwong, J Nicholls, CP Lau, Eur J Heart Failure 2007 9 747 753 10.1016/j.ejheart.2007.03.008 (Pubitemid 47212824)
8. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. AA Kocher, MD Schuster, MJ Szabolcs, S Takuma, D Burkhoff, J Wang, S Homma, NM Edwards, S Itescu, Nat Med 2001 7 430 436 10.1038/86498 11283669 (Pubitemid 32298545)
9. Mesenchymal stem cells promote matrix metalloproteinase secretion by cardiac fibroblasts and reduce cardiac ventricular fibrosis after myocardial infarction. C Mias, O Lairez, E Trouche, J Roncalli, D Calise, MH Seguelas, C Ordener, MD Piercecchi-Marti, N Auge, AN Salvayre, P Bourin, A Parini, D Cussac, Stem Cells 2009 27 2734 2743 10.1002/stem.169 19591227
10. Bioenergetic and functional consequences of cellular therapy: activation of endogenous cardiovascular progenitor cells. Q Xiong, L Ye, P Zhang, M Lepley, C Swingen, L Zhang, DS Kaufman, J Zhang, Circ Res 2012 111 455 468 10.1161/CIRCRESAHA.112.269894 22723295
11. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. P Menasche, AA Hagege, JT Vilquin, M Desnos, E Abergel, B Pouzet, A Bel, S Sarateanu, M Scorsin, K Schwartz, P Bruneval, M Benbunan, JP Marolleau, D Duboc, J Am Coll Cardiol 2003 41 1078 1083 10.1016/S0735-1097(03)00092-5 12679204 (Pubitemid 36384891)
12. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. DA Taylor, BZ Atkins, P Hungspreugs, TR Jones, MC Reedy, KA Hutcheson, DD Glower, WE Kraus, Nat Med 1998 4 929 933 10.1038/nm0898-929 9701245 (Pubitemid 28364032)
13. Stem cell therapy for heart failure: are arrhythmias a real safety concern? P Menasche, Circulation 2009 119 2735 2740 10.1161/CIRCULATIONAHA.108. 812693 19470902
14. Purification and characterization of mouse hematopoietic stem cells. GJ Spangrude, S Heimfeld, IL Weissman, Science 1988 241 58 62 10.1126/science. 2898810 2898810
15. Endothelial progenitor cells in neovascularization of infarcted myocardium. K Jujo, M Ii, DW Losordo, J Mol Cell Cardiol 2008 45 530 544 10.1016/j.yjmcc.2008.08.003 18755197
16. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. M Peichev, AJ Naiyer, D Pereira, Z Zhu, WJ Lane, M Williams, MC Oz, DJ Hicklin, L Witte, MA Moore, S Rafii, Blood 2000 95 952 958 10648408 (Pubitemid 30062717)
17. Mesenchymal stem cells. AI Caplan, J Orthopaedic Res 1991 9 641 650 10.1002/jor.1100090504
18. Mesenchymal stem cells: isolation and therapeutics. A Alhadlaq, JJ Mao, Stem Cells Dev 2004 13 436 448 10.1089/scd.2004.13.436 15345137 (Pubitemid 39223294)
19. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. KA Jackson, SM Majka, H Wang, J Pocius, CJ Hartley, MW Majesky, ML Entman, LH Michael, KK Hirschi, MA Goodell, J Clin Invest 2001 107 1395 1402 10.1172/JCI12150 11390421 (Pubitemid 32522033)
20. Multilineage potential of adult human mesenchymal stem cells. MF Pittenger, AM Mackay, SC Beck, RK Jaiswal, R Douglas, JD Mosca, MA Moorman, DW Simonetti, S Craig, DR Marshak, Science 1999 284 143 147 10.1126/science.284. 5411.143 10102814 (Pubitemid 29282067)
21. Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis. V Jeevanantham, M Butler, A Saad, A Abdel-Latif, EK Zuba-Surma, B Dawn, Circulation 2012 126 551 568 10.1161/CIRCULATIONAHA.111.086074 22730444
22. Stem cell treatment for acute myocardial infarction. DM Clifford, SA Fisher, SJ Brunskill, C Doree, A Mathur, S Watt, E Martin-Rendon, Cochrane Database Syst Rev 2012 2 D006536 22336818
23. Bone marrow tinctures for cardiovascular disease: lost in translation. J Rehman, Circulation 2013 127 1935 1937 10.1161/CIRCULATIONAHA.113.002775 23596005
24. Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial. EC Perin, JT Willerson, CJ Pepine, TD Henry, SG Ellis, DX Zhao, GV Silva, D Lai, JD Thomas, MW Kronenberg, AD Martin, RD Anderson, JH Traverse, MS Penn, S Anwaruddin, AK Hatzopoulos, AP Gee, DA Taylor, CR Cogle, D Smith, L Westbrook, J Chen, E Handberg, RE Olson, C Geither, S Bowman, J Francescon, S Baraniuk, LB Piller, LM Simpson, et al. JAMA 2012 307 1717 1726 10.1001/jama.2012.418 22447880
25. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. M Vasa, S Fichtlscherer, A Aicher, K Adler, C Urbich, H Martin, AM Zeiher, S Dimmeler, Circ Res 2001 89 1 E7 10.1161/hh1301.093953 11440984
26. Endothelial progenitor cell senescence is accelerated in both experimental hypertensive rats and patients with essential hypertension. T Imanishi, C Moriwaki, T Hano, I Nishio, J Hypertension 2005 23 1831 1837 10.1097/01.hjh.0000183524.73746.1b (Pubitemid 41830423)
27. At a crossroad: cell therapy for cardiac repair. MA Deutsch, A Sturzu, SM Wu, Circ Res 2013 112 884 890 10.1161/CIRCRESAHA.112.275974 23493304
28. Progenitor cell therapy to treat acute myocardial infarction: the promise of high-dose autologous CD34(+) bone marrow mononuclear cells. JC Poole, AA Quyyumi, Stem Cells Int 2013 2013 658480 23737803
29. Cardiomyocytes can be generated from marrow stromal cells in vitro. S Makino, K Fukuda, S Miyoshi, F Konishi, H Kodama, J Pan, M Sano, T Takahashi, S Hori, H Abe, J Hata, A Umezawa, S Ogawa, J Clin Invest 1999 103 697 705 10.1172/JCI5298 10074487 (Pubitemid 29122423)
30. Mesenchymal stem cells from adult human bone marrow differentiate into a cardiomyocyte phenotype in vitro. W Xu, X Zhang, H Qian, W Zhu, X Sun, J Hu, H Zhou, Y Chen, Exp Biol Med 2004 229 623 631 (Pubitemid 38878907)
31. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. C Toma, MF Pittenger, KS Cahill, BJ Byrne, PD Kessler, Circulation 2002 105 93 98 10.1161/hc0102.101442 11772882 (Pubitemid 34049148)
32. Cell-to-cell contact induces mesenchymal stem cell to differentiate into cardiomyocyte and smooth muscle cell. T Wang, Z Xu, W Jiang, A Ma, Int J Cardiol 2006 109 74 81 10.1016/j.ijcard.2005.05.072 16122823
33. Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. GV Silva, S Litovsky, JA Assad, AL Sousa, BJ Martin, D Vela, SC Coulter, J Lin, J Ober, WK Vaughn, RV Branco, EM Oliveira, R He, YJ Geng, JT Willerson, EC Perin, Circulation 2005 111 150 156 10.1161/01.CIR.0000151812. 86142.45 15642764 (Pubitemid 40139725)
34. Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction. A Behfar, S Yamada, R Crespo-Diaz, JJ Nesbitt, LA Rowe, C Perez-Terzic, V Gaussin, C Homsy, J Bartunek, A Terzic, J Am Coll Cardiol 2010 56 721 734 10.1016/j.jacc.2010.03.066 20723802
35. Mesenchymal stem cells provide better results than hematopoietic precursors for the treatment of myocardial infarction. A Arminan, C Gandia, JM Garcia-Verdugo, E Lledo, C Trigueros, A Ruiz-Sauri, MD Minana, P Solves, R Paya, JA Montero, P Sepulveda, J Am Coll Cardiol 2010 55 2244 2253 10.1016/j.jacc.2009.08.092 20466205
36. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. SL Chen, WW Fang, F Ye, YH Liu, J Qian, SJ Shan, JJ Zhang, RZ Chunhua, LM Liao, S Lin, JP Sun, Am J Cardiol 2004 94 92 95 10.1016/j.amjcard. 2004.03.034 15219514 (Pubitemid 38813459)
37. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. JM Hare, JH Traverse, TD Henry, N Dib, RK Strumpf, SP Schulman, G Gerstenblith, AN DeMaria, AE Denktas, RS Gammon, JB Hermiller Jr, MA Reisman, GL Schaer, W Sherman, J Am Coll Cardiol 2009 54 2277 2286 10.1016/j.jacc.2009.06.055 19958962
38. Intramyocardial stem cell injection in patients with ischemic cardiomyopathy: functional recovery and reverse remodeling. AR Williams, B Trachtenberg, DL Velazquez, I McNiece, P Altman, D Rouy, AM Mendizabal, PM Pattany, GA Lopera, J Fishman, JP Zambrano, AW Heldman, JM Hare, Circ Res 2011 108 792 796 10.1161/CIRCRESAHA.111.242610 21415390
39. Immunomodulatory activity of mesenchymal stem cells. JM Kaplan, ME Youd, TA Lodie, Curr Stem Cell Res Ther 2011 6 297 316 10.2174/157488811797904353 21190531
40. Immunosuppressive properties of mesenchymal stem cells: advances and applications. MP De Miguel, S Fuentes-Julian, A Blazquez-Martinez, CY Pascual, MA Aller, J Arias, F Arnalich-Montiel, Curr Mol Med 2012 12 574 591 10.2174/156652412800619950 22515979
41. Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial. JM Hare, JE Fishman, G Gerstenblith, DL DiFede Velazquez, JP Zambrano, VY Suncion, M Tracy, E Ghersin, PV Johnston, JA Brinker, E Breton, J Davis-Sproul, IH Schulman, J Byrnes, AM Mendizabal, MH Lowery, D Rouy, P Altman, C Wong Po Foo, P Ruiz, A Amador, J Da Silva, IK McNiece, AW Heldman, JAMA 2012 308 2369 2379 10.1001/jama.2012.25321 23117550
42. Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics. J Bartunek, A Behfar, D Dolatabadi, M Vanderheyden, M Ostojic, J Dens, B El Nakadi, M Banovic, B Beleslin, M Vrolix, V Legrand, C Vrints, JL Vanoverschelde, R Crespo-Diaz, C Homsy, M Tendera, S Waldman, W Wijns, A Terzic, J Am Coll Cardiol 2013 61 2329 2338 10.1016/j.jacc.2013.02.071 23583246
43. Improved cell survival and paracrine capacity of human embryonic stem cell-derived mesenchymal stem cells promote therapeutic potential for pulmonary arterial hypertension. Y Zhang, S Liao, M Yang, X Liang, MW Poon, CY Wong, J Wang, Z Zhou, SK Cheong, CN Lee, HF Tse, Q Lian, Cell Transpl 2012 21 2225 2239 10.3727/096368912X653020
44. Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice. Q Lian, Y Zhang, J Zhang, HK Zhang, X Wu, FF Lam, S Kang, JC Xia, WH Lai, KW Au, YY Chow, CW Siu, CN Lee, HF Tse, Circulation 2010 121 1113 1123 10.1161/CIRCULATIONAHA.109.898312 20176987
45. Cardiac stem cells and myocardial disease. J Kajstura, K Urbanek, M Rota, C Bearzi, T Hosoda, R Bolli, P Anversa, A Leri, J Mol Cell Cardiol 2008 45 505 513 10.1016/j.yjmcc.2008.05.025 18598700
46. Imaging survival and function of transplanted cardiac resident stem cells. Z Li, A Lee, M Huang, H Chun, J Chung, P Chu, G Hoyt, P Yang, J Rosenberg, RC Robbins, JC Wu, J Am Coll Cardiol 2009 53 1229 1240 10.1016/j.jacc.2008.12.036 19341866
47. Local activation or implantation of cardiac progenitor cells rescues scarred infarcted myocardium improving cardiac function. M Rota, ME Padin-Iruegas, Y Misao, A De Angelis, S Maestroni, J Ferreira-Martins, E Fiumana, R Rastaldo, ML Arcarese, TS Mitchell, A Boni, R Bolli, K Urbanek, T Hosoda, P Anversa, A Leri, J Kajstura, Circ Res 2008 103 107 116 10.1161/CIRCRESAHA.108.178525 18556576
48. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. RR Makkar, RR Smith, K Cheng, K Malliaras, LE Thomson, D Berman, LS Czer, L Marban, A Mendizabal, PV Johnston, SD Russell, KH Schuleri, AC Lardo, G Gerstenblith, E Marban, Lancet 2012 379 895 904 10.1016/S0140-6736(12)60195-0 22336189
49. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. R Bolli, AR Chugh, D D'Amario, JH Loughran, MF Stoddard, S Ikram, GM Beache, SG Wagner, A Leri, T Hosoda, F Sanada, JB Elmore, P Goichberg, D Cappetta, NK Solankhi, I Fahsah, DG Rokosh, MS Slaughter, J Kajstura, P Anversa, Lancet 2011 378 1847 1857 10.1016/S0140-6736(11)61590-0 22088800
50. The existence of myocardial repair: mechanistic insights and enhancements. M Schoenfeld, WH Frishman, A Leri, J Kajstura, P Anversa, Cardiol Rev 2013 21 111 120 10.1097/CRD.0b013e318289d7a9 23568056
51. Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction. AR Williams, KE Hatzistergos, B Addicott, F McCall, D Carvalho, V Suncion, AR Morales, J Da Silva, MA Sussman, AW Heldman, JM Hare, Circulation 2013 127 213 223 10.1161/CIRCULATIONAHA.112.131110 23224061
52. Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization. JQ He, Y Ma, Y Lee, JA Thomson, TJ Kamp, Circ Res 2003 93 32 39 10.1161/01.RES.0000080317.92718.99 12791707 (Pubitemid 36859038)
53. Functional cardiomyocytes derived from human induced pluripotent stem cells. J Zhang, GF Wilson, AG Soerens, CH Koonce, J Yu, SP Palecek, JA Thomson, TJ Kamp, Circ Res 2009 104 30 e41 10.1161/CIRCRESAHA.108.192237 19213953
54. Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. O Caspi, I Huber, I Kehat, M Habib, G Arbel, A Gepstein, L Yankelson, D Aronson, R Beyar, L Gepstein, J Am Coll Cardiol 2007 50 1884 1893 10.1016/j.jacc.2007.07.054 17980256 (Pubitemid 350007960)
55. Transcriptional and functional profiling of human embryonic stem cell-derived cardiomyocytes. F Cao, RA Wagner, KD Wilson, X Xie, JD Fu, M Drukker, A Lee, RA Li, SS Gambhir, IL Weissman, RC Robbins, JC Wu, PloS One 2008 3 3474 10.1371/journal.pone.0003474 18941512
56. Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium. E Kolossov, T Bostani, W Roell, M Breitbach, F Pillekamp, JM Nygren, P Sasse, O Rubenchik, JW Fries, D Wenzel, C Geisen, Y Xia, Z Lu, Y Duan, R Kettenhofen, S Jovinge, W Bloch, H Bohlen, A Welz, J Hescheler, SE Jacobsen, BK Fleischmann, J Exp Med 2006 203 2315 2327 10.1084/jem.20061469 16954371 (Pubitemid 44498366)
57. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. MA Laflamme, KY Chen, AV Naumova, V Muskheli, JA Fugate, SK Dupras, H Reinecke, C Xu, M Hassanipour, S Police, C O'Sullivan, L Collins, Y Chen, E Minami, EA Gill, S Ueno, C Yuan, J Gold, CE Murry, Nat Biotechnol 2007 25 1015 1024 10.1038/nbt1327 17721512 (Pubitemid 47517637)
58. Human embryonic stem cell-derived cardiomyocytes survive and mature in the mouse heart and transiently improve function after myocardial infarction. LW van Laake, R Passier, J Monshouwer-Kloots, AJ Verkleij, DJ Lips, C Freund, K den Ouden, D Ward-van Oostwaard, J Korving, LG Tertoolen, CJ van Echteld, PA Doevendans, CL Mummery, Stem Cell Res 2007 1 9 24 10.1016/j.scr.2007.06.001 19383383 (Pubitemid 350251944)
59. Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts. Y Shiba, S Fernandes, WZ Zhu, D Filice, V Muskheli, J Kim, NJ Palpant, J Gantz, KW Moyes, H Reinecke, B Van Biber, T Dardas, JL Mignone, A Izawa, R Hanna, M Viswanathan, JD Gold, MI Kotlikoff, N Sarvazyan, MW Kay, CE Murry, MA Laflamme, Nature 2012 489 322 325 10.1038/nature11317 22864415
60. Human embryonic stem cell-derived cardiomyocytes engraft but do not alter cardiac remodeling after chronic infarction in rats. S Fernandes, AV Naumova, WZ Zhu, MA Laflamme, J Gold, CE Murry, J Mol Cell Cardiol 2010 49 941 949 10.1016/j.yjmcc.2010.09.008 20854826
61. Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. J Nussbaum, E Minami, MA Laflamme, JA Virag, CB Ware, A Masino, V Muskheli, L Pabon, H Reinecke, CE Murry, FASEB J 2007 21 1345 1357 10.1096/fj.06-6769com 17284483 (Pubitemid 46684837)
62. Overexpression of Kir2.1 channel in embryonic stem cell-derived cardiomyocytes attenuates posttransplantation proarrhythmic risk in myocardial infarction. SY Liao, HF Tse, YC Chan, P Mei-Chu Yip, Y Zhang, Y Liu, RA Li, Heart Rhythm 2013 10 273 282 10.1016/j.hrthm.2012.10.008 23041574
63. Stem cell-derived cardiomyocytes demonstrate arrhythmic potential. YM Zhang, C Hartzell, M Narlow, SC Dudley Jr, Circulation 2002 106 1294 1299 10.1161/01.CIR.0000027585.05868.67 12208808 (Pubitemid 34988651)
64. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. K Takahashi, K Tanabe, M Ohnuki, M Narita, T Ichisaka, K Tomoda, S Yamanaka, Cell 2007 131 861 872 10.1016/j.cell.2007.11.019 18035408 (Pubitemid 350138099)
65. Induced pluripotent stem cell lines derived from human somatic cells. J Yu, MA Vodyanik, K Smuga-Otto, J Antosiewicz-Bourget, JL Frane, S Tian, J Nie, GA Jonsdottir, V Ruotti, R Stewart, II Slukvin, JA Thomson, Science 2007 318 1917 1920 10.1126/science.1151526 18029452
66. Bioengineered myocardium derived from induced pluripotent stem cells improves cardiac function and attenuates cardiac remodeling following chronic myocardial infarction in rats. K Miki, H Uenaka, A Saito, S Miyagawa, T Sakaguchi, T Higuchi, T Shimizu, T Okano, S Yamanaka, Y Sawa, Stem Cells Transl Med 2012 1 430 437 10.5966/sctm.2011-0038 23197822
67. Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model. M Kawamura, S Miyagawa, K Miki, A Saito, S Fukushima, T Higuchi, T Kawamura, T Kuratani, T Daimon, T Shimizu, T Okano, Y Sawa, Circulation 2012 126 29 S37 10.1161/CIRCULATIONAHA.111.084343 22965990
68. Intramyocardial transplantation of undifferentiated rat induced pluripotent stem cells causes tumorigenesis in the heart. Y Zhang, D Wang, M Chen, B Yang, F Zhang, K Cao, PloS One 2011 6 19012 10.1371/journal.pone.0019012 21552563
69. Human induced pluripotent stem cells develop teratoma more efficiently and faster than human embryonic stem cells regardless the site of injection. I Gutierrez-Aranda, V Ramos-Mejia, C Bueno, M Munoz-Lopez, PJ Real, A Macia, L Sanchez, G Ligero, JL Garcia-Parez, P Menendez, Stem Cells 2010 28 1568 1570 10.1002/stem.471 20641038
70. Generation of mouse induced pluripotent stem cells without viral vectors. K Okita, M Nakagawa, H Hyenjong, T Ichisaka, S Yamanaka, Science 2008 322 949 953 10.1126/science.1164270 18845712
71. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. L Warren, PD Manos, T Ahfeldt, YH Loh, H Li, F Lau, W Ebina, PK Mandal, ZD Smith, A Meissner, GQ Daley, AS Brack, JJ Collins, C Cowan, TM Schlaeger, DJ Rossi, Cell Stem Cell 2010 7 618 630 10.1016/j.stem.2010.08.012 20888316
72. Survival, integration, and differentiation of cardiomyocyte grafts: a study in normal and injured rat hearts. H Reinecke, M Zhang, T Bartosek, CE Murry, Circulation 1999 100 193 202 10.1161/01.CIR.100.2.193 10402450 (Pubitemid 29330019)
73. Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity. P Liang, F Lan, AS Lee, T Gong, V Sanchez-Freire, Y Wang, S Diecke, K Sallam, JW Knowles, PJ Wang, PK Nguyen, DM Bers, RC Robbins, JC Wu, Circulation 2013 127 1677 1691 10.1161/CIRCULATIONAHA.113.001883 23519760
74. Evaluating the utility of cardiomyocytes from human pluripotent stem cells for drug screening. E Dick, D Rajamohan, J Ronksley, C Denning, Biochem Soc Trans 2010 38 1037 1045 10.1042/BST0381037 20659000
75. Monitoring of bone marrow cell homing into the infarcted human myocardium. M Hofmann, KC Wollert, GP Meyer, A Menke, L Arseniev, B Hertenstein, A Ganser, WH Knapp, H Drexler, Circulation 2005 111 2198 2202 10.1161/01.CIR.0000163546.27639.AA 15851598 (Pubitemid 40632435)
76. Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials. D Hou, EA Youssef, TJ Brinton, P Zhang, P Rogers, ET Price, AC Yeung, BH Johnstone, PG Yock, KL March, Circulation 2005 112 150 I156 16159808
77. Mesenchymal stem cells modified with stromal cell-derived factor 1 alpha improve cardiac remodeling via paracrine activation of hepatocyte growth factor in a rat model of myocardial infarction. J Tang, J Wang, L Guo, X Kong, J Yang, F Zheng, L Zhang, Y Huang, Mol Cells 2010 29 9 19 10.1007/s10059-010-0001-7 20016947
78. Enhanced mesenchymal cell engraftment by IGF-1 improves left ventricular function in rats undergoing myocardial infarction. C Enoki, H Otani, D Sato, T Okada, R Hattori, H Imamura, Int J Cardiol 2010 138 9 18 10.1016/j.ijcard.2009. 04.012 19411121
79. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. AA Mangi, N Noiseux, D Kong, H He, M Rezvani, JS Ingwall, VJ Dzau, Nat Med 2003 9 1195 1201 10.1038/nm912 12910262 (Pubitemid 37173705)
80. Vascular endothelial growth factor-expressing mesenchymal stem cell transplantation for the treatment of acute myocardial infarction. R Matsumoto, T Omura, M Yoshiyama, T Hayashi, S Inamoto, KR Koh, K Ohta, Y Izumi, Y Nakamura, K Akioka, Y Kitaura, K Takeuchi, J Yoshikawa, Arterioscler Thromb Vasc Biol 2005 25 1168 1173 10.1161/01.ATV.0000165696.25680.ce 15831811 (Pubitemid 40776604)
81. Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium. KL Christman, AJ Vardanian, Q Fang, RE Sievers, HH Fok, RJ Lee, J Am Coll Cardiol 2004 44 654 660 10.1016/j.jacc.2004.04.040 15358036 (Pubitemid 39089073)
82. Combining adult stem cells and polymeric devices for tissue engineering in infarcted myocardium. JP Karam, C Muscari, CN Montero-Menei, Biomaterials 2012 33 5683 5695 10.1016/j.biomaterials.2012.04.028 22594970
83. Fabrication of cardiac patch with decellularized porcine myocardial scaffold and bone marrow mononuclear cells. B Wang, A Borazjani, M Tahai, AL Curry, DT Simionescu, J Guan, F To, SH Elder, J Liao, J Biomed Mater Res A 2010 94 1100 1110 20694977
84. Transplantation of cardiac progenitor cell sheet onto infarcted heart promotes cardiogenesis and improves function. L Zakharova, D Mastroeni, N Mutlu, M Molina, S Goldman, E Diethrich, MA Gaballa, Cardiovasc Res 2010 87 40 49 10.1093/cvr/cvq027 20118202
85. Collagen matrices enhance survival of transplanted cardiomyoblasts and contribute to functional improvement of ischemic rat hearts. I Kutschka, IY Chen, T Kofidis, T Arai, G von Degenfeld, AY Sheikh, SL Hendry, J Pearl, G Hoyt, R Sista, PC Yang, HM Blau, SS Gambhir, RC Robbins, Circulation 2006 114 167 I173 16820568
86. Induced regeneration-the progress and promise of direct reprogramming for heart repair. RC Addis, JA Epstein, Nat Med 2013 19 829 836 10.1038/nm.3225 23836233